Lisa A. Peterson

Subscribe to Lisa A. Peterson's Posts
Lisa A. Peterson focuses her practice on antitrust, regulatory and litigation matters. She assists clients across a variety of industries and has represented numerous clients in the health care, pharmaceutical, and biotechnology industries. Lisa advises clients on mergers and acquisitions, including obtaining clearance from the Federal Trade Commission (FTC) and Department of Justice (DOJ), as well as counsels clients on issues regarding antitrust compliance, pricing, and distribution. She also counsels clients on cartel prosecutions and defenses, including government investigations and the initiation and defense of civil class action litigation. Read Lisa Peterson's full bio.

THE LATEST: DOJ Antitrust Chief Casts Doubt on Using “Behavioral Remedies” to Fix Problematic “Vertical” Mergers


By and on Nov 17, 2017
Posted In DOJ Developments, Mergers & Acquisitions

WHAT HAPPENED: On Thursday, November 16, 2017, newly confirmed Assistant Attorney General for Antitrust Makan Delrahim, speaking at the American Bar Association Section of Antitrust Law’s Fall Forum, explained where antitrust enforcement fits in the broader Trump administration effort to reduce federal regulations. Delrahim remarked that “antitrust is law enforcement, it’s not regulation.” Antitrust enforcement...

Continue Reading



Senate Democrats Push for Tougher Merger Enforcement


By , and on Sep 18, 2017
Posted In DOJ Developments, FTC Developments, Mergers & Acquisitions

On September 14, 2017, Senator Amy Klobuchar (D-MN), introduced new legislation to curtail market concentration and enhance antitrust scrutiny of mergers and acquisitions. As the Ranking Member of the Senate Judiciary Committee’s Subcommittee on Antitrust, Competition Policy and Consumer Rights, Klobuchar is the leading Senate Democrat for antitrust issues. Two bills were submitted to the...

Continue Reading



THE LATEST: DOJ’s Packaged Seafood Probe Yields Conditional Leniency Applicant


By on Sep 14, 2017
Posted In Cartel Enforcement, DOJ Developments, Mergers & Acquisitions

On Monday, September 11, Tri-Union Seafoods LLC, the US subsidiary of Thai Union Group, announced it blew the whistle on competitors in the US Department of Justice’s (DOJ) investigation of the packaged seafood industry. The “Chicken of the Sea” canned tuna manufacturer also said it received conditional leniency from DOJ in exchange for its cooperation....

Continue Reading



Bag Fee Case Highlights Antitrust Risk Of Public Statements


By and on Apr 12, 2017
Posted In Cartel Enforcement, FTC Developments, Private Litigation, Uncategorized

For publicly traded companies, earnings calls are routine business events, as are press releases, speeches, investor conferences and trade association meetings. However, in the world of antitrust law, words uttered in these situations can provide fodder for plaintiffs to claim that instead of providing information for investors and the public, the communication’s purpose was to...

Continue Reading



Virginia’s Certificate of Need Laws May Stay, Fourth Circuit Says


By on Jan 26, 2016
Posted In DOJ Developments, FTC Developments

On January 21, the U.S. Court of Appeals for the Fourth Circuit upheld Virginia’s Certificate of Need (CON) laws, ruling that the scheme does not illegally discriminate against out-of-state health care providers. See Colon Health Ctrs. v. Hazel, No. 14-2283 (4th Cir. Jan. 21, 2015). In Virginia, and the 35 other states with CON laws,...

Continue Reading



FTC and Pennsylvania Attorney General Challenge Health System Combination


By , and on Jan 7, 2016
Posted In FTC Developments, Healthcare Antitrust, Joint Ventures/Competitor Collaboration, Power Markets

The Federal Trade Commission (FTC) and Pennsylvania Attorney General (AG) have challenged the proposed combination of The Penn State Hershey Medical Center (Hershey) and PinnacleHealth System (Pinnacle) in Harrisburg, Pennsylvania. The FTC complaint alleges that the combination would create a dominant provider, reduce the number of competing health systems in the area from three to...

Continue Reading



FTC Releases Section 5 Guidelines


By and on Aug 14, 2015
Posted In FTC Developments

On Thursday, August 13, 2015, the Federal Trade Commission (FTC) released a Statement of Enforcement Principles Regarding “Unfair Methods of Competition” Under Section 5 of the FTC Act. The statement was passed by a 4–1 vote, with Commissioner Ohlhausen voting against the statement. This is the first time the Commission has issued formal guidelines regarding its...

Continue Reading



Supreme Court Asked to Clarify the Reach of U.S. Antitrust Laws to Foreign Conduct


By and on Mar 24, 2015
Posted In Cartel Enforcement, DOJ Developments, Private Litigation

On March 16, 2015, AU Optronics Corporation America Inc. (AU Optronics) and Motorola Mobility LLC separately asked the U.S. Supreme Court to clarify the Foreign Trade Antitrust Improvements Act (FTAIA) and the extent to which its language allows foreign conduct to be brought within the scope of the Sherman Act.  The requests for review follow...

Continue Reading



FTC Rule Change Simplifies Process Following a Denial of a Preliminary Injunction Motion


By on Mar 18, 2015
Posted In FTC Developments, Mergers & Acquisitions

On March 14, 2015, the Federal Trade Commission (FTC) announced procedural revisions governing the FTC process when it loses an injunction bid in federal court, to block the consummation of a merger pending its in-house administrative proceedings on the legality of the merger. When the FTC seeks to challenge a merger, the FTC generally seeks...

Continue Reading



FTC and DOJ Host Workshop Examining Health Care Competition


By , , , and on Mar 4, 2015
Posted In DOJ Developments, FTC Developments, Healthcare Antitrust, Mergers & Acquisitions

The Federal Trade Commission (FTC) and the Antitrust Division of the U.S. Department of Justice (DOJ) held a public workshop on February 24–25, 2015, to examine recent trends and developments in health care provider organization and payment models, and their potential effects on competition in the provision of health care services. A main message from...

Continue Reading



BLOG EDITORS

STAY CONNECTED

TOPICS

ARCHIVES

Ranked In Chambers USA 2022
US Leading Firm 2022